LY2624587

LY2624587 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY2624587, covering 2012-01-24 to 2012-01-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2624587 in Patients With Advanced Cancer [Phase 1]